Sugemalimab is the world\'s first anti-PD-L1 monoclonal antibody approved for the treatment of gastric or gastroesophageal junction (G/GEJ) adenocarcinoma. The GEMSTONE-303 study results support sugem
DUBAI,UAE,Feb. 25,2025-- Emirates,as the international airline based in Dubai,has announced its first series of pilot recruitment roadshows in Macao Special Administrative Region,China to meet the str
HONG KONG,Feb. 25,2025--Sino Group(\'the Group\') is pleased to announce that Sino Land Company Limited (\'Sino Land\') (Stock Code: 0083.HK) has been recognised as one of the first developers in Hong
HONG KONG,Feb. 25,2025-- In the digital age,the global financial industry is undergoing rapid transformation,and Hong Kong\'s Fusion Bank has just unveiled a significant milestone in its digital infra
BEIJING,Feb. 25,2025-- The digital cooperation between Singapore and China holds exceptional promise,given their mutual commitment to technological innovation and digital transformation. Singapore,wit
SHANGHAI,Feb. 25,2025-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK,"CARsgen Therapeutics"),a company focused on innovative CAR T-cell therapies for the treatment of hematolo
